论文信息 - Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial. - 字舞流文

Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.

K. Flaherty | R. Kurzrock | L. Hart | N. Le | J. Bendell | H. Burris | J. Infante | L. Fecher | Yanmei Xu | D. Demarini | W. Messersmith | S. Morris | C. Becerra | G. Falchook | M. Gordon | V. Peddareddigari | G. Eckhardt | D. Cox | S. Nallapareddy